English

TIANYIN PHARMACEUTICAL CO., INC.

EDGAR

Quarterly report amendment (10-Q/A) · filed 2015-08-20

51 filing records in this dataset, filed from 2006-11-20 to 2015-08-20. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

17.5 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 17528578 USD Source

Operating margin

12.24%

2011-09-30 · %

Exact inputs and evidence

Operating Income: 2145886 USD Source
Revenue: 17528578 USD Source

Operating cash flow

3.62 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 3624785 USD Source

Cash and cash equivalents: 33.3 million USD 2011-09-30 Source
Exact value

33307292 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

90.8 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 25333853 USD · 2010-10-01 – 2010-12-31 Source
Revenue: 24880980 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 95200928 USD · 2010-07-01 – 2011-06-30 Source
Revenue: 72165647 USD · 2010-07-01 – 2011-03-31 Source
Revenue: 17528578 USD · 2011-07-01 – 2011-09-30 Source

Net income

13.8 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: 5955815 USD · 2010-10-01 – 2010-12-31 Source
Net income: 4061909 USD · 2011-01-01 – 2011-03-31 Source
Net income: 15663012 USD · 2010-07-01 – 2011-06-30 Source
Net income: 13422242 USD · 2010-07-01 – 2011-03-31 Source
Net income: 1525240 USD · 2011-07-01 – 2011-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-08-20.

Financial data available through: 2011-06-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2011-06-30
Operating income: 7 of 11 periods available· newest 2011-06-30
Net income: 7 of 11 periods available· newest 2011-06-30
Operating cash flow: 7 of 11 periods available· newest 2011-06-30
Capital expenditure: 5 of 11 periods available· newest 2011-06-30
Total assets: 6 of 11 periods available· newest 2011-06-30
Total liabilities: 6 of 11 periods available· newest 2011-06-30
Current assets: 6 of 11 periods available· newest 2011-06-30
Current liabilities: 5 of 11 periods available· newest 2011-06-30
Cash and cash equivalents: 7 of 11 periods available· newest 2011-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+48.9%

Prior period

USD 63.94 million

2009-07-01 – 2010-06-30
Current period

USD 95.2 million

2010-07-01 – 2011-06-30

Exact inputs and evidence

95200928 − 63939684 = 31261244 USD

63939684 USD · 2009-07-01 – 2010-06-30
Inspect prior input Prior source
95200928 USD · 2010-07-01 – 2011-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Year-over-year change in Revenue: 31261244 USD Concept: fundies:Revenue Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 95200928 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4249 Input fundies:Revenue: 63939684 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4249
The citation records this snapshot. The page link may show a newer release later.
Net income
+31.8%

Prior period

USD 11.89 million

2009-07-01 – 2010-06-30
Current period

USD 15.66 million

2010-07-01 – 2011-06-30

Exact inputs and evidence

15663012 − 11886286 = 3776726 USD

11886286 USD · 2009-07-01 – 2010-06-30
Inspect prior input Prior source
15663012 USD · 2010-07-01 – 2011-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Year-over-year change in Net income: 3776726 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 15663012 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4365 Input fundies:NetIncome: 11886286 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4365
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-7.9%

Prior period

USD 15.4 million

2009-07-01 – 2010-06-30
Current period

USD 14.19 million

2010-07-01 – 2011-06-30

Exact inputs and evidence

14186216 − 15400098 = -1213882 USD

15400098 USD · 2009-07-01 – 2010-06-30
Inspect prior input Prior source
14186216 USD · 2010-07-01 – 2011-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Year-over-year change in Operating cash flow: -1213882 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 14186216 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060 Input fundies:OperatingCashFlow: 15400098 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-99.8%

Prior period

USD 59,946

2009-07-01 – 2010-06-30
Current period

USD 124

2010-07-01 – 2011-06-30

Exact inputs and evidence

124 − 59946 = -59822 USD

59946 USD · 2009-07-01 – 2010-06-30
Inspect prior input Prior source
124 USD · 2010-07-01 – 2011-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Year-over-year change in Capital expenditure: -59822 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 124 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076 Input fundies:CapitalExpenditure: 59946 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-07-01 – 2011-06-30

Revenue USD 95.2 million 100% of revenue
Cost of revenue USD 52.7 million 55% of revenue
Operating expenses USD 24.43 million 26% of revenue
Operating income USD 18.07 million 19% of revenue
Tax, interest and other Derived USD 2.41 million 2.5% of revenue
Net income USD 15.66 million 16% of revenue

Cash

Operating cash flow USD 14.19 million 15% of revenue
Capital expenditure USD 124 0% of revenue
Free cash flow Derived USD 14.19 million 15% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Operating loss: operating costs were 207% of revenue.
2006 Operating loss: operating costs were 739% of revenue.
2007 19%11%69%
2008 18%77%
2009 18%77%
2010 19%77%
2011 16%81%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	22515	46498 Derived	-23983	-708 Derived	-23275	Unavailable	Source 2005-01-01 – 2005-12-31: 22515 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -23983 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -23275 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 9326 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	6943	51330 Derived	-44387	-426 Derived	-43961	Unavailable	Source 2006-01-01 – 2006-12-31: 6943 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -44387 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -43961 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -19713 USD Inspect Operating Cash Flow Open source
2007 2006-07-01 – 2007-06-30	20369293	14156449 Derived	6212844	2265316 Derived	3947528	4459464 Derived	Source 2006-07-01 – 2007-06-30: 20369293 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: 6212844 USD Inspect Operating Income Open source 2006-07-01 – 2007-06-30: 3947528 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: 4522862 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 63398 USD Inspect Capital Expenditure Open source
2008 2007-07-01 – 2008-06-30	33459609	25890888 Derived	7568721	1597413 Derived	5971308	3497852 Derived	Source 2007-07-01 – 2008-06-30: 33459609 USD Inspect Revenue Open source 2007-07-01 – 2008-06-30: 7568721 USD Inspect Operating Income Open source 2007-07-01 – 2008-06-30: 5971308 USD Inspect Net Income Open source 2007-07-01 – 2008-06-30: 3708917 USD Inspect Operating Cash Flow Open source 2007-07-01 – 2008-06-30: 211065 USD Inspect Capital Expenditure Open source
2009 2008-07-01 – 2009-06-30	42894355	33177760 Derived	9716595	1808985 Derived	7907610	8278984 Derived	Source 2008-07-01 – 2009-06-30: 42894355 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: 9716595 USD Inspect Operating Income Open source 2008-07-01 – 2009-06-30: 7907610 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: 8336998 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 58014 USD Inspect Capital Expenditure Open source
2010 2009-07-01 – 2010-06-30	63939684	49193547 Derived	14746137	2859851 Derived	11886286	15340152 Derived	Source 2009-07-01 – 2010-06-30: 63939684 USD Inspect Revenue Open source 2009-07-01 – 2010-06-30: 14746137 USD Inspect Operating Income Open source 2009-07-01 – 2010-06-30: 11886286 USD Inspect Net Income Open source 2009-07-01 – 2010-06-30: 15400098 USD Inspect Operating Cash Flow Open source 2009-07-01 – 2010-06-30: 59946 USD Inspect Capital Expenditure Open source
2011 2010-07-01 – 2011-06-30	95200928	77127064 Derived	18073864	2410852 Derived	15663012	14186092 Derived	Source 2010-07-01 – 2011-06-30: 95200928 USD Inspect Revenue Open source 2010-07-01 – 2011-06-30: 18073864 USD Inspect Operating Income Open source 2010-07-01 – 2011-06-30: 15663012 USD Inspect Net Income Open source 2010-07-01 – 2011-06-30: 14186216 USD Inspect Operating Cash Flow Open source 2010-07-01 – 2011-06-30: 124 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 95.2M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	22515	Revenue: 22515 Open source
20062006-12-31	Revenue	6943	Revenue: 6943 Open source
20072007-06-30	Revenue	20369293	Revenue: 20369293 Open source
20082008-06-30	Revenue	33459609	Revenue: 33459609 Open source
20092009-06-30	Revenue	42894355	Revenue: 42894355 Open source
20102010-06-30	Revenue	63939684	Revenue: 63939684 Open source
20112011-06-30	Revenue	95200928	Revenue: 95200928 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

48.9% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 22515 Open source
20062006-12-31	Year over year	-69.2%	Revenue: 6943 Open source Revenue: 22515 Open source
20072007-06-30	Year over year	No prior comparable period	Revenue: 20369293 Open source
20082008-06-30	Year over year	64.3%	Revenue: 33459609 Open source Revenue: 20369293 Open source
20092009-06-30	Year over year	28.2%	Revenue: 42894355 Open source Revenue: 33459609 Open source
20102010-06-30	Year over year	49.1%	Revenue: 63939684 Open source Revenue: 42894355 Open source
20112011-06-30	Year over year	48.9%	Revenue: 95200928 Open source Revenue: 63939684 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 19% 2011

Net margin 16.5% 2011

Free cash flow margin 14.9% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Operating margin	-106.5%	Operating Income: -23983 Open source Revenue: 22515 Open source
20062006-12-31	Operating margin	-639.3%	Operating Income: -44387 Open source Revenue: 6943 Open source
20072007-06-30	Operating margin	30.5%	Operating Income: 6212844 Open source Revenue: 20369293 Open source
20082008-06-30	Operating margin	22.6%	Operating Income: 7568721 Open source Revenue: 33459609 Open source
20092009-06-30	Operating margin	22.7%	Operating Income: 9716595 Open source Revenue: 42894355 Open source
20102010-06-30	Operating margin	23.1%	Operating Income: 14746137 Open source Revenue: 63939684 Open source
20112011-06-30	Operating margin	19%	Operating Income: 18073864 Open source Revenue: 95200928 Open source
20052005-12-31	Net margin	-103.4%	Net Income: -23275 Open source Revenue: 22515 Open source
20062006-12-31	Net margin	-633.2%	Net Income: -43961 Open source Revenue: 6943 Open source
20072007-06-30	Net margin	19.4%	Net Income: 3947528 Open source Revenue: 20369293 Open source
20082008-06-30	Net margin	17.8%	Net Income: 5971308 Open source Revenue: 33459609 Open source
20092009-06-30	Net margin	18.4%	Net Income: 7907610 Open source Revenue: 42894355 Open source
20102010-06-30	Net margin	18.6%	Net Income: 11886286 Open source Revenue: 63939684 Open source
20112011-06-30	Net margin	16.5%	Net Income: 15663012 Open source Revenue: 95200928 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 22515 Open source Operating Cash Flow: 9326 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 6943 Open source Operating Cash Flow: -19713 Open source
20072007-06-30	Free cash flow margin	21.9%	Revenue: 20369293 Open source Operating Cash Flow: 4522862 Open source Capital Expenditure: 63398 Open source
20082008-06-30	Free cash flow margin	10.5%	Revenue: 33459609 Open source Operating Cash Flow: 3708917 Open source Capital Expenditure: 211065 Open source
20092009-06-30	Free cash flow margin	19.3%	Revenue: 42894355 Open source Operating Cash Flow: 8336998 Open source Capital Expenditure: 58014 Open source
20102010-06-30	Free cash flow margin	24%	Revenue: 63939684 Open source Operating Cash Flow: 15400098 Open source Capital Expenditure: 59946 Open source
20112011-06-30	Free cash flow margin	14.9%	Revenue: 95200928 Open source Operating Cash Flow: 14186216 Open source Capital Expenditure: 124 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 14.2M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	9326	Operating Cash Flow: 9326 Open source
20062006-12-31	Operating cash flow	-19713	Operating Cash Flow: -19713 Open source
20072007-06-30	Operating cash flow	4522862	Operating Cash Flow: 4522862 Open source
20082008-06-30	Operating cash flow	3708917	Operating Cash Flow: 3708917 Open source
20092009-06-30	Operating cash flow	8336998	Operating Cash Flow: 8336998 Open source
20102010-06-30	Operating cash flow	15400098	Operating Cash Flow: 15400098 Open source
20112011-06-30	Operating cash flow	14186216	Operating Cash Flow: 14186216 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 14.2M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: 9326 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -19713 Open source
20072007-06-30	Free cash flow	4459464	Operating Cash Flow: 4522862 Open source Capital Expenditure: 63398 Open source
20082008-06-30	Free cash flow	3497852	Operating Cash Flow: 3708917 Open source Capital Expenditure: 211065 Open source
20092009-06-30	Free cash flow	8278984	Operating Cash Flow: 8336998 Open source Capital Expenditure: 58014 Open source
20102010-06-30	Free cash flow	15340152	Operating Cash Flow: 15400098 Open source Capital Expenditure: 59946 Open source
20112011-06-30	Free cash flow	14186092	Operating Cash Flow: 14186216 Open source Capital Expenditure: 124 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

9.9% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Liabilities / assets	Not reported	No source recorded
20062006-12-31	Liabilities / assets	41.2%	Total Liabilities: 62187 Open source Total Assets: 150985 Open source
20072007-06-30	Liabilities / assets	25.7%	Total Liabilities: 4145098 Open source Total Assets: 16123085 Open source
20082008-06-30	Liabilities / assets	10.6%	Total Liabilities: 3910548 Open source Total Assets: 36758921 Open source
20092009-06-30	Liabilities / assets	9.7%	Total Liabilities: 4386399 Open source Total Assets: 45332344 Open source
20102010-06-30	Liabilities / assets	17.5%	Total Liabilities: 12213122 Open source Total Assets: 69739101 Open source
20112011-06-30	Liabilities / assets	9.9%	Total Liabilities: 8921607 Open source Total Assets: 90201169 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.31× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Current assets / current liabilities	Not reported	No source recorded
20062006-12-31	Current assets / current liabilities	Not reported	Current Assets: 125016 Open source
20072007-06-30	Current assets / current liabilities	1.43×	Current Assets: 5747115 Open source Current Liabilities: 4025431 Open source
20082008-06-30	Current assets / current liabilities	5.29×	Current Assets: 20692201 Open source Current Liabilities: 3910548 Open source
20092009-06-30	Current assets / current liabilities	5.39×	Current Assets: 23652335 Open source Current Liabilities: 4386399 Open source
20102010-06-30	Current assets / current liabilities	5.29×	Current Assets: 39537993 Open source Current Liabilities: 7479250 Open source
20112011-06-30	Current assets / current liabilities	5.31×	Current Assets: 47396060 Open source Current Liabilities: 8921607 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 23,275 Exact value Exact value: -23275 USD 2005-01-01 – 2005-12-31: -23275 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2005-12-31 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: -23275 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23275 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-07-000102.txt#749 The citation records this snapshot. The page link may show a newer release later.	USD 9,326 Exact value Exact value: 9326 USD 2005-01-01 – 2005-12-31: 9326 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2005-12-31 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 9326 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9326 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-07-000102.txt#756 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 43,961 Exact value Exact value: -43961 USD 2006-01-01 – 2006-12-31: -43961 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2006-12-31 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: -43961 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43961 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-07-000102.txt#749 The citation records this snapshot. The page link may show a newer release later.	−USD 19,713 Exact value Exact value: -19713 USD 2006-01-01 – 2006-12-31: -19713 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2006-12-31 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: -19713 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19713 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-07-000102.txt#756 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2006-07-01 – 2007-06-30	USD 3.95 million Exact value Exact value: 3947528 USD 2006-07-01 – 2007-06-30: 3947528 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2007-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: 3947528 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: 3947528 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-08-000443.txt#8983 The citation records this snapshot. The page link may show a newer release later.	USD 4.52 million Exact value Exact value: 4522862 USD 2006-07-01 – 2007-06-30: 4522862 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2007-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 4522862 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4522862 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-08-000443.txt#9258 The citation records this snapshot. The page link may show a newer release later.	USD 63,398 Exact value Exact value: 63398 USD 2006-07-01 – 2007-06-30: 63398 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2007-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Capital Expenditure: 63398 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63398 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-08-000443.txt#9298 The citation records this snapshot. The page link may show a newer release later.	USD 4.46 million Calculation and evidence 4522862 − 63398 USD Exact free cash flow: 4459464 USD 2006-07-01 – 2007-06-30: 4522862 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 63398 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2007-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Free cash flow: 4459464 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4522862 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-08-000443.txt#9258 Input fundies:CapitalExpenditure: 63398 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-08-000443.txt#9298 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	USD 5.97 million Exact value Exact value: 5971308 USD 2007-07-01 – 2008-06-30: 5971308 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2008-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: 5971308 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: 5971308 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000131.txt#9804 The citation records this snapshot. The page link may show a newer release later.	USD 3.71 million Exact value Exact value: 3708917 USD 2007-07-01 – 2008-06-30: 3708917 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2008-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 3708917 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3708917 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000131.txt#10112 The citation records this snapshot. The page link may show a newer release later.	USD 211,065 Exact value Exact value: 211065 USD 2007-07-01 – 2008-06-30: 211065 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2008-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Capital Expenditure: 211065 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 211065 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000131.txt#10150 The citation records this snapshot. The page link may show a newer release later.	USD 3.5 million Calculation and evidence 3708917 − 211065 USD Exact free cash flow: 3497852 USD 2007-07-01 – 2008-06-30: 3708917 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 211065 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2008-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Free cash flow: 3497852 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3708917 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000131.txt#10112 Input fundies:CapitalExpenditure: 211065 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000131.txt#10150 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	USD 7.91 million Exact value Exact value: 7907610 USD 2008-07-01 – 2009-06-30: 7907610 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2009-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: 7907610 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: 7907610 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000351.txt#6208 The citation records this snapshot. The page link may show a newer release later.	USD 8.34 million Exact value Exact value: 8336998 USD 2008-07-01 – 2009-06-30: 8336998 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2009-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 8336998 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8336998 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000351.txt#7775 The citation records this snapshot. The page link may show a newer release later.	USD 58,014 Exact value Exact value: 58014 USD 2008-07-01 – 2009-06-30: 58014 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2009-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Capital Expenditure: 58014 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 58014 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000351.txt#7821 The citation records this snapshot. The page link may show a newer release later.	USD 8.28 million Calculation and evidence 8336998 − 58014 USD Exact free cash flow: 8278984 USD 2008-07-01 – 2009-06-30: 8336998 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 58014 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2009-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Free cash flow: 8278984 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8336998 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000351.txt#7775 Input fundies:CapitalExpenditure: 58014 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-10-000351.txt#7821 The citation records this snapshot. The page link may show a newer release later.
2010 2009-07-01 – 2010-06-30	USD 11.89 million Exact value Exact value: 11886286 USD 2009-07-01 – 2010-06-30: 11886286 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2010-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: 11886286 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: 11886286 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4365 The citation records this snapshot. The page link may show a newer release later.	USD 15.4 million Exact value Exact value: 15400098 USD 2009-07-01 – 2010-06-30: 15400098 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2010-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 15400098 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15400098 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060 The citation records this snapshot. The page link may show a newer release later.	USD 59,946 Exact value Exact value: 59946 USD 2009-07-01 – 2010-06-30: 59946 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2010-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Capital Expenditure: 59946 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ACapitalExpenditure&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59946 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076 The citation records this snapshot. The page link may show a newer release later.	USD 15.34 million Calculation and evidence 15400098 − 59946 USD Exact free cash flow: 15340152 USD 2009-07-01 – 2010-06-30: 15400098 USD · Inspect Operating Cash Flow · Source 2009-07-01 – 2010-06-30: 59946 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2010-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Free cash flow: 15340152 USD Concept: free-cash-flow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15400098 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060 Input fundies:CapitalExpenditure: 59946 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076 The citation records this snapshot. The page link may show a newer release later.
2011 2010-07-01 – 2011-06-30	USD 15.66 million Exact value Exact value: 15663012 USD 2010-07-01 – 2011-06-30: 15663012 USD Inspect Net Income Open source Share or cite Citation for Net Income · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Net Income: 15663012 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: 15663012 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#4365 The citation records this snapshot. The page link may show a newer release later.	USD 14.19 million Exact value Exact value: 14186216 USD 2010-07-01 – 2011-06-30: 14186216 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Operating Cash Flow: 14186216 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 14186216 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060 The citation records this snapshot. The page link may show a newer release later.	USD 124 Exact value Exact value: 124 USD 2010-07-01 – 2011-06-30: 124 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Capital Expenditure: 124 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 124 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076 The citation records this snapshot. The page link may show a newer release later.	USD 14.19 million Calculation and evidence 14186216 − 124 USD Exact free cash flow: 14186092 USD 2010-07-01 – 2011-06-30: 14186216 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 124 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TIANYIN PHARMACEUTICAL CO., INC. · 2011-06-30 TIANYIN PHARMACEUTICAL CO., INC. (edgar:1362718) Free cash flow: 14186092 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:44:56Z Snapshot: da4c6031778bd14add53eb5d55614808943f35a9490e2770a5393a6e7b841eb6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362718?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 14186216 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5060 Input fundies:CapitalExpenditure: 124 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362718/0001121781-11-000273.txt#5076 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001362718, 1362718, edgar:1362718

Also known as VISCORP, INC.

TIANYIN PHARMACEUTICAL CO., INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2010-07-01 – 2011-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation